DPHARM 2026

UBC is looking forward to attending DPHARM 2026, the leading forum for clinical operations innovation where senior pharma R&D leaders, biotech executives, and technology innovators converge to advance the science and practice of modernizing clinical trials. This event brings together more than 1,000 industry professionals focused on driving efficiency, reducing patient and site burden, and scaling the next generation of drug development; priorities that are deeply aligned with how UBC approaches evidence generation.

UBC delivers expert-led evidence development solutions designed to generate the critical data required to support stakeholder decision-making at every stage of your program. From integrated evidence generation strategies to modernized study execution and late-stage research, our team helps sponsors design and deliver high-quality programs that meet the expectations of patients, providers, regulators, and payers.

• Integrated Evidence Generation Strategy: End-to-end planning that aligns real-world evidence with regulatory and market access objectives from the outset.
• Modernized Study Design & Execution: Innovative, fit-for-purpose study designs that reduce burden, improve data quality, and accelerate timelines.
• Late-Stage Research: Post-approval studies, registries, and observational research that demonstrate long-term product value and support commercialization.
• Real-World Evidence: Purpose-built strategies that leverage real-world data to generate meaningful insights for patients, providers, and payers.

Connect with UBC at DPHARM 2026 to explore how our evidence development solutions can help you modernize your clinical program and deliver the insights that matter most.